Innovation is part of our DNA – it's in our mission statement: science for a better life
Our overall goal is a true partnership which allows both sides to develop and prosper. We will be a committed partner for the entire duration of our collaboration with you.
We are big enough to deliver, but passionate enough to care about every project! We stand by our commitments and treat our partners with respect.
We are flexible and strive for tailored solutions that will fit both parties’ expectations. We’ll give you a direct contact to help solve any questions that may arise.
Bayer joins forces with companies, startups, and academia to advance promising compounds – small molecules and biological compounds – from pre-clinical stages to marketed products. We also in-license specific discovery and platform technologies to support our own innovative research. Comprehensive alliances with research institutes whose expertise complements our own are also welcomed.
To advance fundamental life-science research we engage in pre-competitive collaboration with partners from academia and industry, patient organizations and regulatory authorities. For instance we actively contribute to the Innovative Medicines Initiative (IMI) and the Structural Genomics Consortium (SGC).
By investing in venture funds we support up-and-coming companies in life sciences. We rely on partners like Versant Ventures, Flagship Ventures and the High Tech Gründerfonds with in-depth expertise and an excellent track record.
The Bayer Lifescience Center (BLSC) is a new venturing unit within Bayer that focuses entirely on the development of fundamental breakthrough innovation for humans, animals, and plants by creating a platform that allows technology combination and know-how amplification. Through a network of partnerships BLSC will tackle fundamental challenges to cure human and animal diseases as well as to advance crop protection.